Voice Analysis for Alzheimer's Disease Detection
Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)
Recruiting
Observational Study
Neurocognitive Disorders
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Other
Who this trial is looking for
This trial is looking for older adults to help develop a tool that uses speech patterns to detect early signs of Alzheimer's disease. Participants will contribute data from their regular healthcare routines.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 50 years old or older
- I have a relevant diagnosis with available biomarker data
- I am cognitively healthy or have very mild dementia
- I can understand the study information in the given language
- I agree to participate in the study
You may not be able to join if
- I have hearing problems
- I am protected by law or under guardianship
- I am not able to participate in a clinical study according to French law
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PLATA aims to develop an algorithm to identify vocal biomarkers of Alzheimer's dementia.
Using data collected as part of routine care, speech patterns will be compared to known biomarkers of Alzheimer's disease, such as amyloid 1-42 and p-Tau in CSF (cerebrospinal fluid).
If biomarkers of speech can be identified in Alzheimer's disease, it is possible that patients and research participants will…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 50 years
* Diagnosis relevant biomarker and neuropsychological data already available
* Cognitively healthy to very mild dementia (CDR score max. 0.5)
* Sufficient knowledge of the study language to understand study information, non opposition form,and questionnaires
* E…
Contacts